Doctoral Admissions 2026–2027: “Pharmaceutical Sciences, Biotechnology, and Therapeutic Innovation”
2026-09-18
Annex to Decision No. 049, dated September 17, 2026, accrediting the University of Medea to offer doctoral training within the Doctoral School of “Pharmaceutical Sciences, Biotechnology, and Therapeutic Innovation,” and defining the number of pedagogical seats opened for the 2026–2027 academic year.